Sartorius Stedim Biotech and BD Diagnostics Strengthen Co-operation in the Area of Microbiological Diagnostics

Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, and BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, have announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories. 

“Through our agreement with BD, we have created an excellent collaboration. BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD’s expertise combined with Sartorius Stedim Biotech’s know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring,” says Dominique Baly, member of the Sartorius Group Executive Committee. 

Based on its many years of expertise in the development of membranes, SSB offers high-quality, single-use filter products for concentration of microbial contaminants in the lab. As part of this strategic collaboration, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products. In addition, the companies are exploring options of extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics. 

“The products we plan to develop under our agreement with SSB will enhance laboratory efficiencies for our pharmaceutical, biotech and research customers with these unique product offerings,” said Bob Ferguson, Vice President and General Manager, BD Diagnostics — Diagnostic Systems, Industrial Microbiology. “By combining SSB’s bioprocessing and filtration expertise with BD’s microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing.”